Ryan Watts
Founder presso DENALI THERAPEUTICS INC.
Patrimonio netto: 50 M $ in data 31/03/2024
Profilo
Il dott. Ryan J. Watts è presidente, amministratore delegato e direttore di Denali Therapeutics, Inc. Fa parte del Consiglio di amministrazione di Denali Therapeutics, Inc. Il dott. Watts è stato precedentemente impiegato come direttore del dipartimento di neuroscienze presso Genentech, Inc. Si è laureato all'Università dello Utah e ha conseguito il dottorato alla Stanford University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
DENALI THERAPEUTICS INC.
1.75% | 29/03/2024 | 2 440 671 ( 1.75% ) | 50 M $ | 31/03/2024 |
Posizioni attive di Ryan Watts
| Società | Posizione | Inizio |
|---|---|---|
| DENALI THERAPEUTICS INC. | Founder | 14/10/2013 |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | 23/02/2023 |
Precedenti posizioni note di Ryan Watts
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Founder | 01/02/2015 |
Formazione di Ryan Watts
| Stanford University | Doctorate Degree |
| University of Utah | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Borsa valori
- Insiders
- Ryan Watts
